DOKKYO MEDICAL UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1973-01-01
- Employees
- -
- Market Cap
- -
Clinical Trials
105
Active:0
Completed:59
Trial Phases
5 Phases
Phase 1:2
Phase 2:7
Phase 3:2
+2 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (104 trials with phase data)• Click on a phase to view related trials
Not Applicable
90 (86.5%)Phase 2
7 (6.7%)Phase 4
3 (2.9%)Phase 1
2 (1.9%)Phase 3
2 (1.9%)Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM
- First Posted Date
- 2014-11-26
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Dokkyo Medical University
- Target Recruit Count
- 30
- Registration Number
- NCT02301806
- Locations
- 🇯🇵
Dokkyo Medical University, Mibu, Tochigo, Japan
Effect of Pioglitazone on Cardiovascular Outcome on Higashi-Saitama Trial in Patients With Type 2 Diabetes
Completed
- Conditions
- Type 2 DiabetesHypertensionDyslipidemiaDiabetic Nephropathy
- First Posted Date
- 2007-01-08
- Last Posted Date
- 2007-01-08
- Lead Sponsor
- Dokkyo Medical University
- Target Recruit Count
- 1000
- Registration Number
- NCT00419484
- Locations
- 🇯🇵
Dokkyo Medical University, Koshigaya Hospital, Koshigaya, Saitama, Japan
News
No news found